Kallyope's Series B Round

Kallyope raised a round of funding on February 22, 2018.

Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic and nutritional product potential of the gut-brain axis. The company integrates cutting-edge technologies in sequenc…

Articles about Kallyope's Series B Round: